As of 12:30 PM on the 2nd, Jinwon Life Sciences is trading at 28,700 KRW, up 1.59% from the previous day. This marks a 17.86% increase compared to October 26. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 31,000 shares. Over the past five days, individual investors have net sold 29,307 shares, while foreigners and institutions have net bought 393 shares and 11,988 shares, respectively.


On October 30, Jinwon Life Sciences was a market topic with the headline "Rising Trend on News of COVID-19 Treatment Development."





[Table] Net Trading Volume of Foreigners and Institutions (Unit: Shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing